Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Venous Thrombosis and CYP2C9[original query] |
---|
CYP2C9 polymorphism studies in the Saudi population. Saudi medical journal 2011 Apr 32 (4): 347-52. Saour Jalal N, Shereen Atia W, Saour Basil J, Mammo Layla |
Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis. Thrombosis research 2014 May 133 (5): 729-35. De Tanima, Christopher Rita, Nagaraja Dindag |
High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol. Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study. Genetic testing and molecular biomarkers 2017 Sep . Ju Shang, Gao Yu, Cao Xin, Zhang Xiao-Fu, Yan Cheng-Cheng, Liu Feng-To |
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report. Thrombosis journal 2022 10 20 (1): 65. Aldiban Weam, Altawil Yara, Hussein Samir, Aljamali Majd, Youssef Lama |
- Page last reviewed:Feb 1, 2024
- Content source: